| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
87,992 |
76,096 |
$5.49M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
17,481 |
5,240 |
$593K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
34,499 |
29,981 |
$397K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,765 |
4,336 |
$243K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,932 |
1,845 |
$161K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,980 |
4,603 |
$150K |
| 87581 |
|
3,417 |
3,154 |
$123K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,413 |
1,333 |
$119K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,819 |
7,442 |
$109K |
| 87428 |
|
3,388 |
3,077 |
$66K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,586 |
6,203 |
$65K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,685 |
3,513 |
$60K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
645 |
619 |
$59K |
| 36415 |
Collection of venous blood by venipuncture |
12,318 |
11,402 |
$44K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,924 |
4,023 |
$41K |
| J0558 |
Injection, penicillin g benzathine and penicillin g procaine, 100,000 units |
284 |
270 |
$35K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,435 |
964 |
$34K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
1,668 |
1,531 |
$32K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,946 |
1,852 |
$31K |
| 87400 |
|
3,086 |
2,420 |
$27K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,678 |
5,341 |
$26K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,862 |
4,536 |
$25K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
733 |
692 |
$22K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,589 |
1,262 |
$20K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
221 |
213 |
$18K |
| 82570 |
|
3,976 |
3,539 |
$15K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
168 |
139 |
$13K |
| 81001 |
|
3,151 |
2,838 |
$9K |
| 80061 |
Lipid panel |
1,162 |
1,094 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
104 |
100 |
$7K |
| 90474 |
|
682 |
660 |
$7K |
| 84450 |
|
1,184 |
1,156 |
$6K |
| 84460 |
|
1,190 |
1,162 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
203 |
191 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,051 |
976 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
465 |
440 |
$4K |
| 87807 |
|
408 |
349 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
186 |
146 |
$3K |
| 81003 |
|
1,406 |
1,203 |
$3K |
| 99381 |
|
25 |
24 |
$2K |
| 99173 |
|
784 |
743 |
$2K |
| 90686 |
|
1,062 |
1,008 |
$2K |
| 99490 |
Ccm add 20min |
309 |
301 |
$2K |
| 97162 |
|
42 |
38 |
$2K |
| 0011A |
|
61 |
61 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
30 |
29 |
$2K |
| 92551 |
|
267 |
252 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
168 |
168 |
$2K |
| 3044F |
|
284 |
280 |
$2K |
| 86308 |
|
336 |
315 |
$2K |
| 80076 |
|
320 |
295 |
$2K |
| 0012A |
|
41 |
41 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
203 |
171 |
$1K |
| 0001A |
|
39 |
39 |
$1K |
| 99051 |
|
103 |
89 |
$1K |
| 0002A |
|
30 |
30 |
$939.80 |
| 0072A |
|
29 |
29 |
$903.93 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
427 |
379 |
$862.05 |
| 80305 |
|
161 |
145 |
$854.49 |
| 0071A |
|
19 |
19 |
$688.71 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
137 |
127 |
$585.53 |
| 99307 |
|
39 |
35 |
$513.98 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
92 |
92 |
$423.10 |
| 3288F |
|
148 |
148 |
$370.38 |
| 90682 |
|
60 |
60 |
$332.44 |
| G0008 |
Administration of influenza virus vaccine |
113 |
112 |
$285.56 |
| 74019 |
|
15 |
14 |
$283.88 |
| 99442 |
|
55 |
46 |
$283.04 |
| 95117 |
|
28 |
13 |
$223.14 |
| 87510 |
|
12 |
12 |
$220.55 |
| 85610 |
|
55 |
41 |
$220.52 |
| 87480 |
|
12 |
12 |
$200.50 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
26 |
26 |
$168.95 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
64 |
64 |
$148.27 |
| 82044 |
|
54 |
53 |
$125.21 |
| 1101F |
|
65 |
65 |
$120.65 |
| 81025 |
|
41 |
30 |
$119.39 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
39 |
39 |
$84.19 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
99 |
40 |
$81.09 |
| 82948 |
|
17 |
17 |
$62.69 |
| 82947 |
|
14 |
14 |
$51.34 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
13 |
13 |
$46.03 |
| 93000 |
|
12 |
12 |
$45.73 |
| 99000 |
|
710 |
668 |
$34.20 |
| 85018 |
|
13 |
13 |
$20.46 |
| 90656 |
|
13 |
13 |
$15.05 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
24 |
13 |
$3.05 |
| 90697 |
|
78 |
72 |
$0.00 |
| 3011F |
|
80 |
66 |
$0.00 |
| 90698 |
|
239 |
238 |
$0.00 |
| 36416 |
|
180 |
158 |
$0.00 |
| 1126F |
|
309 |
278 |
$0.00 |
| 3075F |
|
23 |
16 |
$0.00 |
| 90723 |
|
202 |
201 |
$0.00 |
| 90647 |
|
85 |
81 |
$0.00 |
| 1036F |
|
815 |
713 |
$0.00 |
| 90696 |
|
37 |
37 |
$0.00 |
| 90651 |
|
170 |
161 |
$0.00 |
| 1034F |
|
39 |
27 |
$0.00 |
| 3074F |
|
409 |
360 |
$0.00 |
| 3079F |
|
100 |
86 |
$0.00 |
| 90744 |
|
54 |
54 |
$0.00 |
| 1125F |
|
46 |
41 |
$0.00 |
| 90677 |
|
32 |
29 |
$0.00 |
| 90681 |
|
568 |
558 |
$0.00 |
| 90670 |
|
1,222 |
1,201 |
$0.00 |
| 90648 |
|
461 |
457 |
$0.00 |
| 3078F |
|
445 |
393 |
$0.00 |
| 3077F |
|
76 |
60 |
$0.00 |
| 90734 |
|
116 |
108 |
$0.00 |
| 90715 |
|
164 |
159 |
$0.00 |
| 90710 |
|
69 |
67 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
70 |
64 |
$0.00 |
| 1159F |
|
656 |
550 |
$0.00 |
| 90633 |
|
231 |
213 |
$0.00 |
| 1160F |
|
656 |
551 |
$0.00 |
| 90671 |
|
70 |
55 |
$0.00 |
| 90649 |
|
49 |
42 |
$0.00 |